Items Tagged ‘General’

April 21st, 2017

Immunotherapy for Glioblastoma Well Tolerated; Survival Gains Observed

By

Small, phase one trial of a dendritic cell vaccine supports further study in larger trials A phase one study of 11 patients with glioblastoma who received injections of an investigational vaccine therapy and an approved chemotherapy showed the combination to be well tolerated while also resulting in unexpectedly significant survival increases, researchers at the Duke […]

View full entry

Tags: General, glioblastoma, immunotherapy, News, Other News Topics (not Types of Cancer)


March 31st, 2017

FDA Approves Bavencio as First Treatment for Merkel Cell Cancer

By

The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy. This is the first FDA-approved treatment for metastatic MCC. According to the National Cancer Institute, approximately […]

View full entry

Tags: Bavencio, General, Merkel Cell Cancer, News, PD-1, Skin Cancer


March 23rd, 2017

SWOG Launches National Immunotherapy Clinical Trial for Rare Cancers

By

People with rare cancers now have the option of joining a national clinical trial testing leading-edge immunotherapies for a wide variety of tumor types. It’s the first federally funded immunotherapy trial devoted to rare cancers. Despite their name, rare cancers make up more than 20 percent of cancers diagnosed worldwide. The trial is called DART, […]

View full entry

Tags: All Cancer Types, General, immunotherapy, keytruda, Neuroblastoma, News, Other News Topics (not Types of Cancer), Retinoblastoma, Sarcoma, Vaginal Cancer


March 17th, 2017

Dealing with Distress

By

Why it’s important to acknowledge distress during cancer care and what to do about it By Teresa L. Deshields and Clorinda Walley The moment a patient is diagnosed with cancer, one symptom is likely to surface: distress. Sadness, fear, helplessness, anger, social concerns, depression, anxiety, panic – just about everyone that has cancer suffers distress […]

View full entry

Tags: General, general cancer, News


March 1st, 2017

Xermelo-new option for controlling symptoms of Carcinoid Syndrome

By

The US Food and Drug Administration (FDA) today approved the oral therapy Xermelo (telotristat ethyl) to be used in combination with somatostatin analog (SSA) therapy for the treatment of adults with carcinoid syndrome diarrhea. Carcinoid syndrome is a cluster of symptoms that occurs in patients with advanced neuroendocrine tumors (NET) and the related diarrhea results […]

View full entry

Tags: carcinoid syndrome, General, NET, neuroendocrine tumors, News, Other News Topics (not Types of Cancer), Xermelo


February 23rd, 2017

Cancer Connect Launches On line Community for Patients with Neuroendocrine Tumors

By

Sun Valley ID & Austin TX— OMNI Health Media (OMNI) announces the launch of a new online community on CancerConnect for individuals with neuroendocrine tumors (NET). This community will provide patients and their loved ones with information and support. Join the conversation in the NET community here. Although neuroendocrine tumors have historically been considered rare, […]

View full entry

Tags: General, neuroendocrine tumors, News, Other News Topics (not Types of Cancer)


October 7th, 2016

It’s in the Genes: Genetic Testing Tutorial

By

Advances in genetic testing are offering women more information than ever before about their genetic makeup and are providing opportunities for empowered decision making related to a wide range of health issues. In this recurring column, experts provide vital information about how genetic testing suits one’s individual needs, potential risks and benefits, and the role […]

View full entry

Tags: General, News, Other News Topics (not Types of Cancer)


July 19th, 2016

Loxo Oncology Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for LOXO-101

By

Loxo Oncology, Inc. (LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to LOXO-101, a selective inhibitor of tropomyosin receptor kinase (TRK), “for the treatment of unresectable or metastatic solid tumors with NTRK-fusion […]

View full entry

Tags: All Cancer Types, Breakthrough Therapy Designation, FDA. BTD, General, LOXO-101, metastatic solid tumors, News, TRK fusions, unresectable


August 19th, 2015

Smoking Cessation Drug Not Boosting Number of Smokers Who Quit

By

The introduction of a new prescription smoking-cessation aid, varenicline, in 2006 has had no significant impact on the rate at which Americans age 18 and older successfully quit smoking, according to a study led by researchers at University of California, San Diego School of Medicine. The findings, published online August 17 in Tobacco Control, suggest […]

View full entry

Tags: cessation aides, Chantix, General, Other News Topics (not Types of Cancer), quit smoking, tobacco control, varenicline


August 12th, 2015

FDA Designates Breakthrough Therapy Designation for Azedra in Pheochromocytoma and Paraganglioma

By

The U.S. Food and Drug Administration (FDA) has designated Azedra as a Breakthrough Therapy for the treatment of patients with iobenguane-avid metastatic or recurrent pheochromocytoma and paraganglioma. Azedra is currently being evaluated in a pivotal Phase 2b trial, which is being conducted under a Special Protocol Assessment Agreement (SPA), and has received Orphan Drug and […]

View full entry

Tags: azedra, General, News, Other News Topics (not Types of Cancer), Paraganglioma, Pheochromocytoma


July 13th, 2015

theGIConnection and the Inflammatory Bowel Disease Support Foundation Partner to Provide Crohn’s Disease and Ulcerative Colitis Patients with Virtual Support Community

By

July 13, 2015 – Fort Worth TX/Sun Valley ID —OMNI Health Media (OMNI) and the Inflammatory Bowel Disease Support Foundation (IBDSF) are pleased to announce a partnership with TheGIConnection that will both improve access to and increase support of patients and their families impacted by a diagnosis of Crohn’s disease or ulcerative colitis, collectively known as […]

View full entry

Tags: Chron's disease, General, Inflammatory Bowel Disease Support Foundation, online community, Other News Topics (not Types of Cancer), theGIConnection, ulcerative colitis


November 10th, 2014

Tips for Cancer Caregivers: November is National Family Caregiver Month

By

Caring for a family member or friend with cancer is often very challenging. The experience can be exhausting both mentally and physically, but it actually becomes even more so when you don’t take care of yourself. I use a metaphor of a watering can and a garden to drive home this point. If your loved […]

View full entry

Tags: All Cancer Types, cancer caregiver, caregiver, caregiver support, General, News, Other News Topics (not Types of Cancer), support, Types of Cancer


October 15th, 2014

Study Suggest That Psoriasis Patients Have Increased Cancer Risk

By

Based on recently analyzed data from a retrospective analysis of commercial insurance claims, rates of cancer are higher in patients with psoriasis and that some anti-psoriatic drugs may pose a higher risk than others. Dr. Alexa B. Kimball of Massachusetts General Hospital reported at the American Academy of Dermatology summer meeting that rates for all […]

View full entry

Tags: cancer, General, News, Other News Topics (not Types of Cancer), psoriasis


October 14th, 2014

Anamorelin May Be First Drug to Treat Cancer Cachexia

By

A new drug, anamorelin, may be the first ever to effectively improve cancer cachexia. These findings were presented at the 2014 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain, September 26–30.[1] Cancer cachexia is a “wasting” condition in which the patient progressively loses significant amounts of bodyweight and muscle mass and suffers from […]

View full entry

Tags: anamorelin, appetite, cachexia, cancer, General, Lung Cancer - Non-Small Cell, News, nutrition, Other News Topics (not Types of Cancer), Stages IIIB-IV Lung Cancer - Non-Small Cell


October 6th, 2014

New Studies Suggest Cancer Treatments During Pregnancy May Be Safe

By

Two small studies presented at the European Society for Medical Oncology annual meeting suggest that children whose mothers undergo chemotherapy or radiation for cancer during pregnancy are not at increased risk for mental development or heart problems. Although previous studies have suggested it is safe to give cancer treatment during pregnancy, some doctors and pregnant […]

View full entry

Tags: cancer and pregnancy, General, News, Other News Topics (not Types of Cancer), pregnancy, radiation therapy